We investigated the efficacy of thyroglobulin antibodies (TgAb) in detecting malignancy.
This retrospective study included 1646 patients who had undergone preoperative FNAB.
Multifocality (P = .002), bilaterality (P = .003), lymph-node metastasis (P = .030), and capsule penetration (P = .003) were significantly associated with positive TgAb in papillary thyroid carcinoma (PTC) patients.
TgAb positivity (P <.001) and preoperative TSH levels (P = .022) were independent predictive factor for PTC.
Preoperative TgAb could be a marker for PTC in patients with indeterminate thyroid nodules.